17 Recruiting Solid Tumor, Adult Phase 1 / Phase 2 Clinical Trials
Active phase 1 / phase 2 studies for solid tumor, adult enrolling across the USA. Verify eligibility and contact site coordinators.
All Solid Tumor, Adult studiesPhase 1 / Phase 2 Studies for Solid Tumor, Adult
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
📍 Florida Cancer Specialists — Sarasota, Florida
View Study & Checklist ➔First-in-Human Study of ICT01 in Patients With Advanced Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
📍 UCLA Hematology/Oncology — Los Angeles, California
View Study & Checklist ➔Study Assessing MTD, Safety, Tolerability, PK and Anti-tumor Effects of LNS8801alone and With Pembrolizumab
📍 Cedars-Sinai Medical Center — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression
📍 Banner Health — Gilbert, Arizona
View Study & Checklist ➔Evaluation of AL3818 in Combination With Nivolumab in Solid Tumors
📍 Sarcoma Oncology Research Center — Santa Monica, California
View Study & Checklist ➔Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔Study to Evaluate D-1553 in Subjects With Solid Tumors
📍 Research Site — Fresno, California
View Study & Checklist ➔Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors
📍 University of Southern California- Norris Cancer Center — Los Angeles, California
View Study & Checklist ➔A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
📍 University of California Los Angeles — Los Angeles, California
View Study & Checklist ➔Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
📍 UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors
📍 MD Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
📍 Site USA12-0 — Los Angeles, California
View Study & Checklist ➔A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
📍 Banner Health — Gilbert, Arizona
View Study & Checklist ➔A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
📍 O'Neal Comprehensive Cancer Center at University of Alabama-Birmingham — Birmingham, Alabama
View Study & Checklist ➔A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
📍 The Angeles Clinic and Research Institute — Los Angeles, California
View Study & Checklist ➔